ICMR to set up blood disorder centre in Maharashtra
New Delhi: The Indian Council of Medical Research (ICMR) on Friday initiated efforts to set up a satellite centre of the National Institute of Immunohaemotology in Maharashtra's Chandrapur district, where genetic blood disorders are on the rise.The purpose of the centre would be to carry out research on haemoglobinopathies, which are a kind of genetic defect that results in abnormal...
Login or Register to read the full article
New Delhi: The Indian Council of Medical Research (ICMR) on Friday initiated efforts to set up a satellite centre of the National Institute of Immunohaemotology in Maharashtra's Chandrapur district, where genetic blood disorders are on the rise.
The purpose of the centre would be to carry out research on haemoglobinopathies, which are a kind of genetic defect that results in abnormal structure of one of the globin chains of the haemoglobin molecule. Common haemoglobinopathies include sickle-cell anaemia, which is an inherited blood disorder.
According to ICMR, tribals constitute nearly 20 percent of the total population of Chandrapur district in Maharashtra. A large proportion of this tribal population is suffering from sickle-cell anaemia (10 percent) and thalassaemia.
An ICMR team of experts surveyed the region and recommended that need-based research studies should be undertaken in this region for early detection, management and control of these disorders.
"The proposed centre will carry out advanced research based on the needs of the region. It will also provide training and education for human resource development in the area," said V.K. Srivastava, head of the ICMR division of publication and information.
"Land has already been acquired for setting up the centre and process has been initiated for construction of the building."
"ICMR acquired a portion of district tuberculosis hospital in Chandrapur to start its research activities. This portion of the hospital is being developed as an interim centre of the proposed satellite centre. A budget of Rs.4.59 crore has been sanctioned for an initial period of five years," he added.
The purpose of the centre would be to carry out research on haemoglobinopathies, which are a kind of genetic defect that results in abnormal structure of one of the globin chains of the haemoglobin molecule. Common haemoglobinopathies include sickle-cell anaemia, which is an inherited blood disorder.
According to ICMR, tribals constitute nearly 20 percent of the total population of Chandrapur district in Maharashtra. A large proportion of this tribal population is suffering from sickle-cell anaemia (10 percent) and thalassaemia.
An ICMR team of experts surveyed the region and recommended that need-based research studies should be undertaken in this region for early detection, management and control of these disorders.
"The proposed centre will carry out advanced research based on the needs of the region. It will also provide training and education for human resource development in the area," said V.K. Srivastava, head of the ICMR division of publication and information.
"Land has already been acquired for setting up the centre and process has been initiated for construction of the building."
"ICMR acquired a portion of district tuberculosis hospital in Chandrapur to start its research activities. This portion of the hospital is being developed as an interim centre of the proposed satellite centre. A budget of Rs.4.59 crore has been sanctioned for an initial period of five years," he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd